Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines

Carcinogenesis

Volumn 31, Issue 9, 2010, Pages 1584-1591

  Brown, Iain ^a   Cascio, Maria G ^a   Wahle, Klaus W J ^a   Smoum, Reem ^b   Mechoulam, Raphael ^b   Ross, Ruth A ^a   Pertwee, Roger G ^a   Heys, Steven D ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; CANNABINOID RECEPTOR; DOCOSAHEXAENOIC ACID; DOCOSAHEXAENOYL ETHANOLAMIDE; EICOSAPENTAENOYL ETHANOLAMIDE; FATTY ACID AMIDASE; ICOSAPENTAENOIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN LNCAP; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENZYME INHIBITION; ENZYME METABOLISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

ADJUVANTS, IMMUNOLOGIC; AMIDOHYDROLASES; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL MEMBRANE; CELL PROLIFERATION; CHO CELLS; CRICETINAE; CRICETULUS; DEHYDROEPIANDROSTERONE; FATTY ACIDS, OMEGA-3; FLOW CYTOMETRY; HUMANS; MALE; MICE; PROSTATIC NEOPLASMS; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 77956278506     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq151     Document Type: Article

References (39)

1. Berquin,I.M. et al. (2008) Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett., 269, 363-377.
2. Shaikh,I.A. et al. (2008) Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway. Prostate, 68, 1635-1646.
3. Howlett,A.C. (2002) The cannabinoid receptors. Prostaglandins Other Lipid Mediat., 68-69, 619-631.
4. Wood,J.T. et al. (2010) Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma. J. Lipid Res., 51, 1416-1423.
5. De Petrocellis,L. et al. (1998) The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc. Natl Acad. Sci. USA, 95, 8375-8380.
6. Mimeault,M. et al. (2003) Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production. Prostate, 56, 1-12.
7. Deutsch,D.G. et al. (1993) Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol., 46, 791-796.
8. Pertwee,R.G. (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther., 74, 129-180.
9. Sheskin,T. et al. (1997) Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. J. Med. Chem., 40, 659-667.
10. Ross,R.A. et al. (1999) Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630. Br. J. Pharmacol., 126, 665-672.
11. Thomas,A. et al. (2004) 6"-Azidohex-2"-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist. Eur. J. Pharmacol., 487, 213-221.
12. Kurkinen,K.M. et al. (1997) Gamma-35S]GTP autoradiography allows region-specific detection of muscarinic receptor-dependent G-protein activation in the chick optic tectum. Brain Res., 769, 21-28.
13. Breivogel,C.S. et al. (2001) Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol., 60, 155-163.
14. Cheng,Y. et al. (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
15. Gong,J.P. et al. (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res., 1071, 10-23.
16. Keith,J.M. et al. (2008) Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase. Bioorg. Med. Chem. Lett., 18, 4838-4843.
17. Artmann,A. et al. (2008) Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim. Biophys. Acta, 1781, 200-212.
18. Melck,D. et al. (2000) Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology, 141, 118-126.
19. Chung,B.H. et al. (2001) Effects of docosahexaenoic acid and eicosapentaenoic acid on androgen-mediated cell growth and gene expression in LNCaP prostate cancer cells. Carcinogenesis, 22, 1201-1206.
20. Sarfaraz,S. et al. (2006) Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest. J. Biol. Chem., 281, 39480-39491.
21. Olea-Herrero,N. et al. (2009) Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2. Br. J. Cancer, 101, 940-950.
22. Carroll,A.G. et al. (1993) P53 oncogene mutations in three human prostate cancer cell lines. Prostate, 23, 123-134.
23. Majumder,B. et al. (2002) Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. FASEB J., 16, 1447-1449.
24. Maccarrone,M. et al. (2000) Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J. Biol. Chem., 275, 31938-31945.
25. Mnich,K. et al. (2010) Inhibition by anandamide of 6-hydroxydopamineinduced cell death in PC12 cells. Int. J. Cell. Biol., 2010, ID:818497.
26. Ligresti,A. et al. (2006) Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J. Pharmacol. Exp. Ther., 318, 1375-1387.
27. Sanchez,M.G. et al. (2003) Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction. Cell. Signal., 15, 851-859.
28. Jan,C.R. et al. (2002) Novel effect of CP55,940, a CB1/CB2 cannabinoid receptor agonist, on intracellular free Ca2+ levels in bladder cancer cells. Chin. J. Physiol., 45, 33-39.
29. Ryan,D. et al. (2007) Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue. Eur. J. Neurosci., 25, 2093-2102.
30. Williams,E.J. et al. (2003) The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response. J. Cell Biol., 160, 481-486.
31. Bifulco,M. et al. (2004) A new strategy to block tumor growth by inhibiting endocannabinoid inactivation. FASEB J., 18, 1606-1608.
32. Sanchez,M.G. et al. (2005) Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue. Eur. J. Pharmacol., 515, 20-27.
33. Matta,J.A. et al. (2007) TRPV1 is a novel target for omega-3 polyunsaturated fatty acids. J. Physiol., 578, 397-411.
34. Cudaback,E. et al. (2010) The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas. PLoS One, 5, e8702.
35. Berger,A. et al. (2001) Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc. Natl Acad. Sci. USA, 98, 6402-6406.
36. Ruiz-Llorente,L. et al. (2004) Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study. Br. J. Pharmacol., 141, 457-467.
37. Rose,D.P. et al. (1996) Effect of omega-3 fatty acids on the progression of metastases after the surgical excision of human breast cancer cell solid tumors growing in nude mice. Clin. Cancer Res., 2, 1751-1756.
38. Wu,M. et al. (2005) Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway. Int. J. Cancer, 117, 340-348.
39. Pertwee,R.G. (2010) Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr. Med. Chem., 17, 1360-1381.